Found 104 matching trials
Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX) PHASE2 Vaccines are used to prevent infectious diseases worldwide. Unfortunately, ...
Show More Location
Radboud University
Learn More & Join Trial
Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA PHASE1 This is a randomized controlled parallel Group phase I study to investigate...
Show More Location
University Hospital Bordeaux (Pellegrin Hospital)
Learn More & Join Trial
Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older. PHASE1 The primary objective of the phase I trial is to evaluate the safety and to...
Show More Location
Zigong Center for Disease Control and Prevention
Learn More & Join Trial
Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine PHASE1 The purpose of this study is to evaluate the safety and immunogenicity of A...
Show More Location
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
Learn More & Join Trial
Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59 PHASE1 This research will study safety and the body's immune (defense system) resp...
Show More Location
Emory Children's Center - Pediatric Infectious Diseases
Learn More & Join Trial
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease PHASE1 The main purpose of this study is to evaluate safety, tolerability and immu...
Show More Location
Clinical Research Services Turku -CRST Oy
Learn More & Join Trial
Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) Patients PHASE3 The purpose of the study is to demonstrate the safety and immunogenicity of...
Show More Location
Clinical Research Associates of Tidewater
Learn More & Join Trial
Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years. EARLY_PHASE1 This is a first in human testing of novel HIV-1 protein nanoparticles vacci...
Show More Location
Nucleus Network Melbourne
Learn More & Join Trial
HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB) PHASE2 A study to evaluate the antiviral effects, immunogenicity, and safety of He...
Show More Location
Paragon Rx Clinical
Learn More & Join Trial
Gene Expression Profiles in Muscle After Immunisation NA This clinical study is part of the BIOVACSAFE project which is funded by th...
Show More Location
Surrey Clinical Research Centre
Learn More & Join Trial